J. M. Bautista , J. M. Manson and L. Luzzatto (1992). Purification and properties of human glucose-6-phosphate dehydrogenase made in E. coli. Biochemica et Biophysica Acta 1119, 74–80.
M. J. Bockarie and R. M. Deb (2010). Elimination of lymphatic filariasis: do we have the drugs to complete the job. Current Opinion in Infectious Diseases 23, 617–620.
M. M. Bradford (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 248–254.
M. Ciftci , S. Beydemir , H. Yilmaz and S. Altikat (2003). Purification of glucose-6-phosphate dehydrogenase from Buffalo (Bubalus bubalis) erythrocytes and investigation of some kinetic properties. Protein Expression and Purification 29, 304–310.
A. T. Cordeiro , O. H. Thiemann and P. A. M. Michels (2009). Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites. Bioorganic and Medicinal Chemistry 17, 2483–2489.
J. Critchley , D. Addiss , H. Ejere , C. Gamble , P. Garner and H. Gelband (2005). Albendazole for the control and elimination of lymphatic filariasis: systematic review. Tropical Medicine and International Health 10, 818–825.
A. Fico , F. Paglialunga , L. Cigliano , P. Abrescia , P. Verde , G. Martini , I. Iaccarino and S. Filosa (2004). Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis. Cell Death and Differentiation 11, 823–831.
S. Filosa , A. Fico , F. Paglialunga , M. Balestrieri , A. Crooke , P. Verde , P. Abrescia , J. M. Bautista and G. Martini (2003). Failure to increase glucose consumption through the pentose phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene deleted mouse embryonic stem cells subjected to oxidative stress. Biochemical Journal 370, 935–943.
S. Gupta , M. Igoillo-Esteve , P. A. M. Michels and A. T. Cordeiro (2011). Glucose-6-phosphate dehydrogenase of trypanosomatids: characterization, target validation and drug discovery. Molecular Biology International 2011, 135701.
G. Gordon , M. C. Mackow and H. R. Levy (1995). On the mechanism of interaction of steroids with human glucose-6-phosphate dehydrogenase. Archives of Biochemistry and Biophysics 318, 25–29.
M. Igoillo-Esteve and J. J. Cazzulo (2006). The glucose-6-phosphate dehydrogenase from Trypanosoma cruzi: its role in the defense of the parasite against oxidative stress. Molecular and Biochemical Parasitology 149, 170–181.
E. M. Klenova , R. H. Nicolas , U. Sally , A. F. Carne , R. E. Lee , V. V. Lobanenkov and G. H. Goodwin (1997). Molecular weight abnormalities of the CTCF transcription factor: CTCF migrates aberrantly in SDS–PAGE and the size of the expressed protein is affected by the UTRs and sequences within the coding region of the CTCF gene. Nucleic Acids Research 25, 466–473.
W. D. Kohn , C. M. Kay and R. S. Hodges (1995). Protein destabilization by electrostatic repulsions in the two stranded alpha helical coiled/coil leucine zipper. Protein Science 4, 237–250.
U. K. Laemmli (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685.
C. Little , T. Sannera and A. Pihl (1969). Stimulation of fructose 1,6-diphosphatase by sulfhydryl reagents and interaction between the different enzymic sites in the molecule. European Journal of Biochemistry 8, 229–236.
P. A. Marks and J. Banks (1960). Inhibition of mammalian glucose-6-phosphate dehydrogenase by steroids. Proceedings of the National Academy of Sciences, USA 46, 447–452.
O. D. Monera , C. M. Kay and R. S. Hodges (1994). Protein denaturation with guanidine hydrochloride or urea provides a different estimate of stability depending on the contributions of electrostatic interactions. Protein Science 3, 1984–1991.
M. Y. Osei-Atweneboana , J. K. Eng , D. A. Boakye , J. O. Gyapong and P. K. Prichard (2007). Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369, 2021–2029.
R. M. Ramzy , M. El Setouhy , H. Helmy , E. S. Ahmed , K. M. Abd Elaziz , H. A. Farid , W. D. Shannon and G. J. Weil (2006). Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367, 992–999.
T. J. Schulz , K. Zarse , A. Voigt , N. Urban , M. Birringer and M. Ristow (2007). Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metabolism 6, 280–293.
A. R. Singh , S. Joshi , R. Arya , A. M. Kayastha , K. K. Srivastava , L. M. Tripathi and J. K. Saxena (2008). Molecular cloning and characterization of Brugia malayi hexokinase. Parasitology International 57, 354–361.
J. E. Smith and M. S. Anwer (1970). Studies on glucose-6-phosphate dehydrogenase. Experientia 27, 835–836.
J. M. Van Raamsdonk and S. Hekimi (2010). Reactive oxygen species and aging in Caenorhabditis elegans: causal or casual relationship. Antioxidants and Redox Signaling 13, 1911–1953.
X. T. Wang and P. C. Engel (2009). An optimised system for refolding of human glucose-6-phosphate dehydrogenase. BMC Biotechnology 9, 19–29.
K. Winiarska , J. Drozak , M. Wegrzynowicz , A. K. Jagielski and J. Bryla (2003). Relationship between gluconeogenesis and glutathione redox state in rabbit kidney-cortex tubules. Metabolism 52, 739–746.
N. G. Wrigley , I. V. Heather , A. Bonsignore and A. De Flore (1972). Human erythrocyte glucose-6-phosphate dehydrogenase: electron microscope studies on structure and interconversation of tetramers, dimers and monomers. Journal of Molecular Biology 68, 483–499.
Z. Zhang , C. W. Liew , D. E. Handy , Y. Zhang , J. A. Leopold , J. Hu , L. Lili Guo , R. N. Kulkarni , J. Loscalzo and R. C. Stanton (2010). High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and β-cell apoptosis. FASEB Journal 24, 1497–1505.